However, MIC predicted htTKV growth rate was substantially misaligned compared to ground truth in the 22 of 36 (60%) ADPKD patients indicating there is opportunity for improvement especially in males and subjects with PKD2 mutations. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.